APEX Tech Acquisition sponsor buys $30.3K in units

Each private unit included an ordinary share and a right tied to completion of the issuer’s initial business combination.

Available on EDGAR 11/05/2026 - 08:38 PM EST Accepted by SEC EDGAR 11/05/2026 - 08:37 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

APEX Tech Acquisition Inc. (TRAD) reported that sponsor Apex Innovation Acquisition Corp. purchased 3,029 private units at $10 each ($30,290 total) on April 15, 2026, when underwriters closed the over-allotment option. Each unit included one ordinary share and a right to receive one-fourth of an ordinary share upon the issuer’s initial business combination; the sponsor’s reported post-purchase holdings were 3,087,000 ordinary shares and 53,000 rights. CEO and CFO and director Shaoren Liu is the sponsor’s sole member and director, has sole voting and investment discretion over its shares, and may be deemed to beneficially own them. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 6,058 shares

Net Buy 2 txns

Insider Liu Shaoren, APEX INNOVATION ACQUISITION CORP.

Role CEO and CFO | 10% Owner

Bought 6,058 shs

Increase in Position 0.10%

Type	Security	Shares	Price	Value
Purchase	Right F2, F1	3,029	--	--
Purchase	Ordinary shares F2, F1	3,029	$10.00	$30K

Holdings After Transaction: Right — 53,000 contracts (Indirect, By Sponsor); Ordinary shares — 3,087,000 shares (Indirect, By Sponsor)

Holdings Before and After: Right, 49,971 to 53,000 contracts (Indirect, By Sponsor); Ordinary shares, 3,083,971 to 3,087,000 shares (Indirect, By Sponsor)

Footnotes (2)

1. F1. Mr. Shaoren Liu is the sole member and sole director of Apex Innovation Acquisition Corp. (the -Sponsor-) and has sole voting and investment discretion with respect to the shares held by the Sponsor and may be deemed to beneficially own those shares.
2. F2. Simultaneously with the closing of the over-allotment option on April 15, 2026 by the underwriters in connection with the Issuers initial public offering, the Sponsor purchased an additional 3,029 private units at $10.00 per private unit, for an aggregate purchase price of $30,290. Each private unit consist of one ordinary share and one right (Right) to receive one-fourth (1/4) of one ordinary share upon consummation of the Issuer's initial business combination.

Key Figures

Private units purchased: 3,029 units Price per private unit: $10 per private unit Aggregate purchase price: $30,290 +3 more

6 metrics

Private units purchased 3,029 units Purchased by the sponsor on April 15, 2026

Price per private unit $10 per private unit Sponsor purchase on April 15, 2026

Aggregate purchase price $30,290 Sponsor purchase of private units

Ordinary shares held after purchase 3,087,000 shares Sponsor’s reported post-purchase holdings

Rights held after purchase 53,000 rights Sponsor’s reported post-purchase holdings

Right entitlement One-fourth of one ordinary share per right Upon consummation of the issuer’s initial business combination

Key Terms

private units, over-allotment option, Right, initial business combination

4 terms

private units financial

"purchased an additional 3,029 private units at $10.00 per private unit"

over-allotment option financial

"closing of the over-allotment option on April 15, 2026"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

Right financial

"one right (Right) to receive one-fourth of one ordinary share"

initial business combination financial

"upon consummation of the issuer’s initial business combination"

An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many private units did TRAD’s sponsor buy, and at what price?

Apex Innovation Acquisition Corp. purchased 3,029 private units at $10 per unit, for an aggregate purchase price of $30,290, on April 15, 2026. The purchase occurred when underwriters closed the over-allotment option. No Rule 10b5-1 plan is reported.

What rights came with TRAD’s private units?

Each private unit included one ordinary share and one right to receive one-fourth of an ordinary share upon consummation of the issuer’s initial business combination.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liu Shaoren

(Last) (First) (Middle)

13501 KATY FWY

(Street)

HOUSTON TEXAS 77079

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APEX Tech Acquisition Inc. [ TRAD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares	04/15/2026		P		3,029(2)	A	$10	3,087,000	I	By Sponsor(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Right	(2)	04/15/2026		P		3,029		(2)	(2)	Ordinary Shares	757	(2)	53,000	I	By Sponsor(1)

1. Name and Address of Reporting Person^*

Liu Shaoren

(Last) (First) (Middle)

13501 KATY FWY

(Street)

HOUSTON TEXAS 77079

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and CFO

1. Name and Address of Reporting Person^*

APEX INNOVATION ACQUISITION CORP.

(Last) (First) (Middle)

13501 KATY FWY

(Street)

HOUSTON TEXAS 77079

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Mr. Shaoren Liu is the sole member and sole director of Apex Innovation Acquisition Corp. (the -Sponsor-) and has sole voting and investment discretion with respect to the shares held by the Sponsor and may be deemed to beneficially own those shares.

2. Simultaneously with the closing of the over-allotment option on April 15, 2026 by the underwriters in connection with the Issuers initial public offering, the Sponsor purchased an additional 3,029 private units at $10.00 per private unit, for an aggregate purchase price of $30,290. Each private unit consist of one ordinary share and one right (Right) to receive one-fourth (1/4) of one ordinary share upon consummation of the Issuer's initial business combination.

	/s/ Shaoren Liu	11/05/2026
	/s/ Shaoren Liu, sole member of Apex Innovation Acquisition Corp.	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)